These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. An overview on microglial origin, distribution, and phenotype in Alzheimer's disease. Islam R; Choudhary H; Rajan R; Vrionis F; Hanafy KA J Cell Physiol; 2024 Jun; 239(6):e30829. PubMed ID: 35822939 [TBL] [Abstract][Full Text] [Related]
4. TREM2 and Microglia Contribute to the Synaptic Plasticity: from Physiology to Pathology. Yu CJ; Wang M; Li RY; Wei T; Yang HC; Yin YS; Mi YX; Qin Q; Tang Y Mol Neurobiol; 2023 Feb; 60(2):512-523. PubMed ID: 36318443 [TBL] [Abstract][Full Text] [Related]
5. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease. Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049 [TBL] [Abstract][Full Text] [Related]
6. TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice. Jiang T; Zhang YD; Chen Q; Gao Q; Zhu XC; Zhou JS; Shi JQ; Lu H; Tan L; Yu JT Neuropharmacology; 2016 Jun; 105():196-206. PubMed ID: 26802771 [TBL] [Abstract][Full Text] [Related]
7. Targeting Microglia-Synapse Interactions in Alzheimer's Disease. Piccioni G; Mango D; Saidi A; Corbo M; Nisticò R Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652870 [TBL] [Abstract][Full Text] [Related]
14. PU.1 regulates Alzheimer's disease-associated genes in primary human microglia. Rustenhoven J; Smith AM; Smyth LC; Jansson D; Scotter EL; Swanson MEV; Aalderink M; Coppieters N; Narayan P; Handley R; Overall C; Park TIH; Schweder P; Heppner P; Curtis MA; Faull RLM; Dragunow M Mol Neurodegener; 2018 Aug; 13(1):44. PubMed ID: 30124174 [TBL] [Abstract][Full Text] [Related]
15. Patterns of Expression of Purinergic Receptor P2RY12, a Putative Marker for Non-Activated Microglia, in Aged and Alzheimer's Disease Brains. Walker DG; Tang TM; Mendsaikhan A; Tooyama I; Serrano GE; Sue LI; Beach TG; Lue LF Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31968618 [TBL] [Abstract][Full Text] [Related]
16. Microglia in Alzheimer's disease: A target for immunotherapy. Wang S; Colonna M J Leukoc Biol; 2019 Jul; 106(1):219-227. PubMed ID: 30725482 [TBL] [Abstract][Full Text] [Related]
17. Evaluating the Role of Microglial Cells in Clearance of Aβ from Alzheimer's Brain. Manchikalapudi AL; Chilakala RR; Kalia K; Sunkaria A ACS Chem Neurosci; 2019 Mar; 10(3):1149-1156. PubMed ID: 30609357 [TBL] [Abstract][Full Text] [Related]
18. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models. Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S Elife; 2020 Jun; 9():. PubMed ID: 32510331 [TBL] [Abstract][Full Text] [Related]
19. Diabetic phenotype in mouse and humans reduces the number of microglia around β-amyloid plaques. Natunen T; Martiskainen H; Marttinen M; Gabbouj S; Koivisto H; Kemppainen S; Kaipainen S; Takalo M; Svobodová H; Leppänen L; Kemiläinen B; Ryhänen S; Kuulasmaa T; Rahunen E; Juutinen S; Mäkinen P; Miettinen P; Rauramaa T; Pihlajamäki J; Haapasalo A; Leinonen V; Tanila H; Hiltunen M Mol Neurodegener; 2020 Nov; 15(1):66. PubMed ID: 33168021 [TBL] [Abstract][Full Text] [Related]